Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.6.3 to v3.6.4, reflecting a minor update to the page's version and metadata.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision tag 'Revision: v3.6.3' was added and the previous tag 'Revision: v3.6.2' was removed, indicating a small update to the page's revision history.SummaryDifference0.1%

- Check29 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2. This reflects a minor template/software update to the page rather than a change to the study details.SummaryDifference0.1%

- Check43 days agoChange DetectedNew navigation and guidance sections were added to the study details page (How to Read a Study Record, Common Questions, How to Join a Study), and a recruitment status indicator 'No longer looking for participants' was introduced. The label formatting for Intervention/Treatment was adjusted and the old heading 'Intervention / Treatment' as well as the older revision tag were removed.SummaryDifference0.4%

- Check50 days agoChange DetectedStudy record metadata was updated to revision v3.5.5, replacing the previous v3.5.4 tag. This reflects a minor update to the page's revision history without changing the study content.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a minor internal update to the study page rather than changes to study data.SummaryDifference0.1%

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.